Aeglea Biotherapeutics shares owned by Barclays
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $2.9M | 123k | 23.29 |
2024-09-30 | $3.1M | 106k | 29.40 |
2024-06-30 | $1.5M | 64k | 23.50 |
2024-03-31 | $1.7M | 46k | 37.93 |
2023-12-31 | $979k | 46k | 21.52 |